AI Drives Progress in Lyme Disease Testing and Adolescent Care
At ADLM, researchers showcase how AI is advancing clinical lab medicine—from improving early Lyme disease detection to helping teens access reliable health information.
At ADLM, researchers showcase how AI is advancing clinical lab medicine—from improving early Lyme disease detection to helping teens access reliable health information.
Researchers developed an advanced diagnostic kit enabling rapid detection and differentiation of H5N1 avian influenza strains.
ARUP Laboratories has been selected by the CDC to develop a rapid-response test for H5N1, addressing the ongoing public health crises.
H5N1 avian flu, historically infecting birds, has recently infected three farm workers. Diagnostic testing may be our best defense.
Read MoreThe development of a quantitative real-time PCR method by researchers enhances the detection of Escherichia Albertii.
Read MoreA study detailed a new Zika virus-specific synthetic molecule that effectively distinguishes Zika from related dengue virus infections.
Read MoreGeorge Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read MoreThe FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read MoreResearchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
Read MoreA study showcased the application of Flongle sequencing as a cost-efficient and rapid method to detect the zoonotic pathogen.
Read MorePicodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MoreA new study has revealed disparities in the diagnosis and treatment of Lyme disease between Black and White patients with the condition.
Read MoreA pilot study demonstrated the importance of self-sampling in diagnosing asymptomatic or atypical cases of mpox.
Read MoreCurrent diagnostic methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood.
Read MoreA rapid test for mpox has been developed that can detect the virus within minutes, without the use of any high-end instrumental techniques.
Read MoreNoze received a grant of $1 million to build a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs).
Read MoreCue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read MoreThe test kit is for use in laboratory settings and can help healthcare professionals accurately identify an Avian Influenza A Virus infection.
Read More